These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23982578)

  • 61. Botulinum toxin A (Botox) for treatment of proximal myofascial pain in complex regional pain syndrome: two cases.
    Safarpour D; Jabbari B
    Pain Med; 2010 Sep; 11(9):1415-8. PubMed ID: 20735753
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evidence against trigger point injection technique for the treatment of cervicothoracic myofascial pain with botulinum toxin type A.
    Ferrante FM; Bearn L; Rothrock R; King L
    Anesthesiology; 2005 Aug; 103(2):377-83. PubMed ID: 16052120
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Injection of botulinum toxin type A (BOTOX) into trigger zone of trigeminal neuralgia as a means to control pain.
    Ngeow WC; Nair R
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):e47-50. PubMed ID: 20219585
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Treatment of myofascial pain syndrome (MPS) with botulinum toxin type A (BoNT-A)].
    Günther O; Bitterlich N
    MMW Fortschr Med; 2011 Jul; 153 Suppl 2():64-9. PubMed ID: 23964470
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Botulinum toxin injection for internal anal sphincter achalasia after pull-through surgery in Hirschsprung disease.
    Youn JK; Han JW; Oh C; Kim SY; Jung SE; Kim HY
    Medicine (Baltimore); 2019 Nov; 98(45):e17855. PubMed ID: 31702647
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bilateral Thyroarytenoid Botulinum Toxin Type A Injection for the Treatment of Refractory Chronic Cough.
    Sasieta HC; Iyer VN; Orbelo DM; Patton C; Pittelko R; Keogh K; Lim KG; Ekbom DC
    JAMA Otolaryngol Head Neck Surg; 2016 Sep; 142(9):881-8. PubMed ID: 27367917
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study.
    Göbel H; Heinze A; Reichel G; Hefter H; Benecke R;
    Pain; 2006 Nov; 125(1-2):82-8. PubMed ID: 16750294
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Botulinum toxin treatment of false vocal folds in adductor spasmodic dysphonia: Functional outcomes.
    Simpson CB; Lee CT; Hatcher JL; Michalek J
    Laryngoscope; 2016 Jan; 126(1):118-21. PubMed ID: 26467807
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy of intra-articular injection of botulinum toxin type A in refractory hemiplegic shoulder pain.
    Castiglione A; Bagnato S; Boccagni C; Romano MC; Galardi G
    Arch Phys Med Rehabil; 2011 Jul; 92(7):1034-7. PubMed ID: 21704782
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Can we justify the continued use of botulinum toxin A in the management of myofascial pain?
    Farrier JN; Farrier S; Haworth S; Beech AN
    Br J Oral Maxillofac Surg; 2020 Nov; 58(9):1133-1138. PubMed ID: 32622616
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Botulinum toxin type A for the treatment of head and neck chronic myofascial pain syndrome: A systematic review and meta-analysis.
    Khalifeh M; Mehta K; Varguise N; Suarez-Durall P; Enciso R
    J Am Dent Assoc; 2016 Dec; 147(12):959-973.e1. PubMed ID: 27737756
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature.
    Vergilis-Kalner IJ
    J Drugs Dermatol; 2011 Sep; 10(9):1013-5. PubMed ID: 22052270
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparison of two botulinum-toxin preparations in the treatment of essential blepharospasm.
    Nüssgens Z; Roggenkämper P
    Graefes Arch Clin Exp Ophthalmol; 1997 Apr; 235(4):197-9. PubMed ID: 9143885
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Botulinum toxin in the treatment of myofascial pain syndrome.
    Cheshire WP; Abashian SW; Mann DJ
    Pain; 1994 Oct; 59(1):65-69. PubMed ID: 7854804
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A prospective randomized double-blinded pilot study to examine the effect of botulinum toxin type A injection versus Lidocaine/Depomedrol injection on residual and phantom limb pain: initial report.
    Wu H; Sultana R; Taylor KB; Szabo A
    Clin J Pain; 2012 Feb; 28(2):108-12. PubMed ID: 21750460
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A double-blind, randomized, comparative study of Dysport vs. Botox in primary palmar hyperhidrosis.
    Simonetta Moreau M; Cauhepe C; Magues JP; Senard JM
    Br J Dermatol; 2003 Nov; 149(5):1041-5. PubMed ID: 14632812
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Surgery or botulinum toxin for adductor spasmodic dysphonia: a comparative study.
    Mendelsohn AH; Berke GS
    Ann Otol Rhinol Laryngol; 2012 Apr; 121(4):231-8. PubMed ID: 22606926
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Four-dimensional ultrasound guidance for pelvic floor Botulinum toxin-A injection in chronic pelvic pain: a novel technique.
    Nesbitt-Hawes EM; Dietz HP; Abbott JA
    Ultrasound Obstet Gynecol; 2018 Mar; 51(3):396-400. PubMed ID: 28557012
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Botox treatment in patients with chronic functional anorectal pain: experiences of a tertiary referral proctology clinic.
    Ooijevaar RE; Felt-Bersma RJF; Han-Geurts IJ; van Reijn D; Vollebregt PF; Molenaar CBH
    Tech Coloproctol; 2019 Mar; 23(3):239-244. PubMed ID: 30778784
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Four-dimensional ultrasound biometry following botulinum toxin type A injection to the pelvic floor.
    Nesbitt-Hawes EM; Dietz HP; Ledger WL; Abbott JA
    Neurourol Urodyn; 2022 Jan; 41(1):375-382. PubMed ID: 34787927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.